Get started
Author

Anna Bowman

Observed name: A. Bowman
ORCID: 0009-0006-5223-8303
Observed ORCID: 0009-0006-5223-8303
OpenAlex ID: A5073408396
Outcomes of Patients With Embolic Stroke of Undetermined Source Treated With Antiplatelet Agents or Anticoagulation
2025 · James Ernest Siegler, Elena Badillo Goicoechea, et al. · Neurology · 9
Recurrent Stroke in Patients With Cryptogenic Stroke and Left Ventricular Injury: The Cardiac Abnormalities in Stroke Prevention and Recurrence (CASPR) Study
2026 · Richa Sharma, Katelyn F. McNamara, et al. · Stroke · 2
Anticoagulation Treatment Response Among Phenotypic ESUS Clusters: Evidence From CASPR
2026 · Elena Badillo Goicoechea, Patrick Ellsworth, et al. · Annals of Clinical and Translational Neurology
PDF
Comprehensive Diagnostic Evaluation and Risk of Recurrent Stroke After Embolic Stroke of Undetermined Source: Introducing the Concept of ESUS 2.0
2026 · Farhan Khan, Christoph Stretz, et al. · Journal of the American Heart Association
Association of Insurance Status on Risk of Stroke Recurrence with Incident Cryptogenic Stroke: A Secondary Analysis of the CASPR Study
2026 · Mary Penckofer, James E. Siegler, et al. · Neuroepidemiology
Real-World Practice in Secondary Stroke Prevention Following Embolic Stroke of Undetermined Source
2026 · Hassan Aboul-Nour, James Ernest Siegler, et al. · Neurology Clinical Practice
Abstract DP154: The Association Between Comprehensive Evaluation in ESUS and Stroke Recurrence: A secondary analysis of the Cardiac Abnormalities in Stroke Prevention and risk of Recurrence Study
2026 · Farhan Khan, Christoph Stretz, et al. · Stroke
Intracranial Occlusion in Cryptogenic Stroke Is Not Predictive of Recurrent Ischemic Stroke: A Propensity‐Score Matched Analysis of the Cardiac Abnormalities in Stroke Prevention and Risk of Recurrence Study
2025 · Matthew M. Smith, James R. Brorson, et al. · Journal of the American Heart Association
Abstract WP300: Anticoagulation versus antiplatelet for secondary prevention in embolic stroke of undetermined source: The Cardiac Abnormalities in Stroke Prevention and Risk of Recurrence Study
2025 · James Siegler, Mary Penckofer, et al. · Stroke
Abstract TP275: Impact of Insurance Status on Risk of Stroke Recurrence with Incident Cryptogenic Stroke: A secondary analysis of the CASPR study
2025 · Mary Penckofer, Eric Goldstein, et al. · Stroke
Abstract DP55: Recurrent Stroke in Patients with Cryptogenic Stroke and Left Ventricular Injury: The Cardiac Abnormalities in Stroke Prevention and Recurrence (CASPR) study
2025 · Richa Sharma, James Siegler, et al. · Stroke
Abstract WP284: Recurrent stroke in patients with incident cryptogenic stroke and underlying malignancy: A secondary analysis of the CASPR study
2025 · Kelsey Eklund, James Siegler, et al. · Stroke
Abstract 027: Intracranial occlusion in cryptogenic stroke is not predictive of recurrent ischemic stroke: A propensity‐score matched analysis of the Cardiac Abnormalities in Stroke Prevention and risk of Recurrence Study
2024 · J. E. Siegler, M. Penckofer, et al. · Stroke Vascular and Interventional Neurology
Area Deprivation Index and Likelihood of Presenting to ED With Sepsis
2024 · A. Bowman, J. Bledsoe, et al.
Insurance Status and Illness Severity on Emergency Department Presentation Among Patients With Community-acquired Sepsis
2023 · A. Bowman, N. Arizmendez, et al.
Works count: 15
Citation count: 9
H-index: 1
I10-index:
Year
Topic
Type